MLK3 Regulates Paxillin Phosphorylation in Chemokine-Mediated Breast Cancer Cell Migration and Invasion to Drive Metastasis

被引:71
作者
Chen, Jian [2 ]
Gallo, Kathleen A. [1 ,3 ]
机构
[1] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA
[3] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA
关键词
FOCAL-ADHESION KINASE; NBT-II CELLS; TYROSINE PHOSPHORYLATION; DUCTAL CARCINOMA; RHO GTPASES; ACTIVATION; EXPRESSION; MET; JNK; PATHWAY;
D O I
10.1158/0008-5472.CAN-12-0655
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MLK3 kinase activates multiple mitogen-activated protein kinases and plays a critical role in cancer cell migration and invasion. In the tumor microenvironment, prometastatic factors drive breast cancer invasion and metastasis, but their associated signaling pathways are not well-known. Here, we provide evidence that MLK3 is required for chemokine (CXCL12)-induced invasion of basal breast cancer cells. We found that MLK3 induced robust phosphorylation of the focal adhesion scaffold paxillin on Ser 178 and Tyr 118, which was blocked by silencing or inhibition of MLK3-JNK. Silencing or inhibition of MLK3, inhibition of JNK, or expression of paxillin S178A all led to enhanced Rho activity, indicating that the MLK3-JNK-paxillin axis limits Rho activity to promote focal adhesion turnover and migration. Consistent with this, MLK3 silencing increased focal adhesions and stress fibers in breast cancer cells. MLK3 silencing also decreased the formation of breast cancer lung metastases in vivo, and breast cancer cells derived from mouse lung metastases showed enhanced Ser 178 paxillin phosphorylation. Taken together, our findings suggest that the MLK3-JNK-paxillin signaling axis may represent a potential therapeutic target and/or prognostic marker in breast cancer metastasis. Cancer Res; 72(16); 4130-40. (C) 2012 AACR.
引用
收藏
页码:4130 / 4140
页数:11
相关论文
共 50 条
[1]   Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma [J].
Azuma, K ;
Tanaka, M ;
Uekita, T ;
Inoue, S ;
Yokota, J ;
Ouchi, Y ;
Sakai, R .
ONCOGENE, 2005, 24 (30) :4754-4764
[2]   CHARACTERIZATION OF TYROSINE PHOSPHORYLATION OF PAXILLIN IN-VITRO BY FOCAL ADHESION KINASE [J].
BELLIS, SL ;
MILLER, JT ;
TURNER, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17437-17441
[3]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[4]   Paxillin: Adapting to change [J].
Brown, MC ;
Turner, CE .
PHYSIOLOGICAL REVIEWS, 2004, 84 (04) :1315-1339
[5]   MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation [J].
Chadee, DN ;
Kyriakis, JM .
NATURE CELL BIOLOGY, 2004, 6 (08) :770-776
[6]   MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells [J].
Chen, J. ;
Miller, E. M. ;
Gallo, K. A. .
ONCOGENE, 2010, 29 (31) :4399-4411
[7]  
Cronan MR, 2011, ONCOGENE
[8]   Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH2-terminal kinase/activator protein-1 signaling to regulate cell migration [J].
Cui, Xiaojiang ;
Kim, Hyun-Jung ;
Kuiatse, Isere ;
Kim, Heetae ;
Brown, Powel H. ;
Lee, Adrian V. .
CANCER RESEARCH, 2006, 66 (10) :5304-5313
[9]   Breast cancer statistics, 2011 [J].
DeSantis, Carol ;
Siegel, Rebecca ;
Bandi, Priti ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (06) :409-418
[10]   Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3 [J].
Du, Y ;
Böck, BC ;
Schachter, KA ;
Chao, M ;
Gallo, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :42984-42993